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Abstract
Livers are comprised of maturational lineages of cells beginning extrahepatically in the hepato-
pancreatic common duct near the duodenum and intrahepatically in zone 1 by the portal triads.
The extrahepatic stem cell niches are the peribiliary glands deep within the walls of the bile ducts;
those intrahepatically are the canals of Hering in postnatal livers and that derive from ductal plates
in fetal livers. Intrahepatically, there are at least 8 maturational lineage stages from the stem cells
in zone 1 (periportal), through the midacinar region (zone 2), to the most mature cells and
apoptotic cells found pericentrally in zone 3. Those found in the biliary tree are still being defined.
Parenchymal cells are closely associated with lineages of mesenchymal cells, and their maturation
is coordinated. Each lineage stage consists of parenchymal and mesenchymal cell partners
distinguishable by their morphology, ploidy, antigens, biochemical traits, gene expression, and
ability to divide. They are governed by changes in chromatin (e.g. methylation), gradients of
paracrine signals (soluble factors and insoluble extracellular matrix components), mechanical
forces, and feedback loop signals derived from late lineage cells. Feedback loop signals, secreted
by late lineage stage cells into bile, flow back to the periportal area and regulate the stem cells and
other early lineage stage cells, in mechanisms dictating the size of the liver mass. Recognition of
8Corresponding Author: LM Reid, UNC School of Medicine, Campus Box 7038, Glaxo Building Rms 32-35, Chapel Hill, NC
27599. Phone: 919-966-0347; FAX: 919-6112. Lola.M.Reid@gmail.com.
7Co-senior authors
Author contributions:
R Turner and LM Reid did most of the writing of the sections on hepatic stem cells, hepatoblasts and maturational lineages of
parenchymal cells and editing of the manuscript. O. Lozoya prepared the sections on mechanical effects on cells. Y. Wang helped with
sections on the biliary tree stem cells and on regulation of the cells by paracrine signaling. C Barbier and E Wauthier helped to edit the
review. The sections on the biliary tree, biliary tree stem cells, and cholangiocytes were written and edited by Drs. G. Alpini, D.
Alvaro, E. Gaudio and V. Cardinale. The schematic figures were drawn by G. Mendel. The authors declare that they have no conflicts.
NIH Public Access
Author Manuscript
Hepatology. Author manuscript; available in PMC 2012 March 1.
Published in final edited form as:













maturational lineage biology and its regulation by these multiple mechanisms offers new
understandings of liver biology, pathologies, and strategies for regenerative medicine.
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hepatic stem cells; hepatoblasts; hepatic maturational lineages; feedback loop signaling;
regenerative medicine
I. The Liver’s Maturational Lineages
Hepatic stem cells and their mesenchymal partners, angioblasts, give rise to daughter cells
maturing into lineages of parenchymal and mesenchymal cells with stepwise changes in cell
size, morphology, ploidy, gene expression, growth potential and signaling(1–4). Currently,
there is evidence for at least 8 intrahepatic lineage stages (Figures 1 and 2)(5–6). Continued
efforts to characterize the liver’s lineage biology should result in recognition of additional
stages. This overview focuses on early intrahepatic lineage stages in human livers and
includes aspects of their regulation. Information on later lineage stages of cells, additional
background and references is included in the online supplement.
Stage 1.Hepatic stem cells (hHpSCs) are multipotent stem cells located within the liver’s
stem cell compartment, the ductal plates of fetal and neonatal livers, and canals of Hering in
pediatric and adult livers(5,7–12). The compartment represents the anatomic and
physiological link between the intralobular canalicular system of hepatocytes and the biliary
tree and resides along sites that project starlike from the portal tracts. They constitute ~0.5–
2% of the parenchyma of livers of all age donors. The hHpSCs cells range in size from 7–
10µm in diameter and have a high nucleus-to-cytoplasm ratio. Tolerant of ischemia, they
can remain viable in cadaveric livers for up to ~6 days after asystolic death(11–12).
The hHpSC phenotypic profile includes epithelial cell adhesion molecule (EpCAM), neural
cell adhesion molecule(NCAM), CD133,CXCR4,SOX9,SOX17,FOXA2, cytokeratins(CK)
8/18/19, Hedgehog proteins (Sonic and Indian), intranuclear telomerase protein, claudin 3,
MDR1, weak expression of albumin and MHC antigens. They do not express α-fetoprotein
(AFP), intercellular adhesion molecule (ICAM-1), P450s, or markers for hemopoietic (e.g.
CD34/38/45/90, glycophorin), endothelial (e.g. VEGFr, CD31, von Willebrand factor) or
mesenchymal cells (e.g. CD146, desmin, vitamin A, CD105)(6–7,13). It remains unclear
whether C-kit(CD117), expressed in the liver’s stem cell niches(8,14–15), is on hHpSCs or
associated angioblasts, as CD117+ flow cytometry selects for angioblasts(7,13).
Some proteins, such as CK19, are synthesized and found in punctuate form, but not
converted to filaments, as seen in hepatoblasts(7). Similarly, little albumin is synthesized but
not packaged as in later lineage stages, implicating lineage-dependent distinctions in post-
transcriptional and translational protein processing.
The hHpSCs are isolated by dual immunoselection for EpCAM+/NCAM+ cells from livers
of all donor ages. In adult livers, which have scarce hepatoblast populations, EpCAM+
selection alone results in predominant hHpSCs isolation(7,16).
In culture, the hHpSCs form colonies capable of self-replication(17) and of differentiation to
mature cells in culture and in vivo(7,18). Cells expand ex vivo if cultured in Kubota’s
Medium, a serum-free medium containing only insulin, transferrin/fe, lipids, no copper, and
low calcium (19–20) or if co-cultured with angioblasts. These feeders are replaceable with
purified type III collagen substrates, low cross-linking hyaluronan hydrogel embedding or a
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mixture of both (13,21). If transplanted in vivo, they yield mature liver tissue. If cultured
under distinct conditions (see below) they lineage-restrict into hepatoblasts(13).
Stage 2.Hepatoblasts(hHBs) are diploid bipotent cells giving rise to hepatocytic and
cholangiocytic lineages, associated with precursors of both endothelia and hepatic stellate
cells, and the liver’s probable transit amplifying cells(13). They reside throughout
parenchyma of fetal and neonatal livers or as single cells and small cell aggregates tethered
to the ends of canals of Hering in adult livers(8). With donor age, hHBs decline to <0.01%
of the parenchymal cells in postnatal livers(7–8). They expand during regenerative processes
associated with certain diseases such as cirrhosis. Previously, hHBs were referred to as
“intermediate hepatobiliary cells of the ductular reactions”(22); extensive characterization
enabled us to update their nomenclature with hepatoblasts(8). They can be isolated by dual
immunoselection for EpCAM+/ICAM-1+. They have enormous expansion potential
cultured in Kubota’s Medium, especially if supplemented with EGF and HGF, or on feeders
of stellate cell precursors replaceable by substrata of type IV collagen, laminin, hyaluronans
or mixtures of these, albeit without proven self-replication(13,23–24).
The hHBs, larger(10–12µm) and with higher amounts of cytoplasm than hHpSCs, have an
antigenic profile that overlaps with hHpSCs(6–7,15). Shared phenotypic traits include
CXCR4, CD133, SOX17, MDR1, cytokeratins(CK) 8/18 and 19, Hedgehog proteins (Sonic
and Indian), and null expression of late P450s (e.g. P450-3A) or markers for hemopoietic,
endothelia or mesenchymal cells (as in hHpSCs). Protein expression changes include
reduction in EpCAM levels with primary localization to plasma membrane surfaces;
filamentous CK14 and CK19(8,15,25); elevated albumin levels with discrete cytoplasmic
packaging(7); switch from NCAM to ICAM-1; expression of early P450s (e.g. P450-A7)
and CK7; and strong positive expression of hepatic-specific AFP, distinct from a
hemopoietic progenitor variant form with alternative splicing of exon 1, a probable clue of
mesendoderm to endoderm differentiation(26). They have approximately 5X the telomerase
activity of hHpSCs and telomerase protein localized both in the nucleus and in the
cytoplasm(27). A comparison of the phenotypic profiles of HpSCs and HBs can be found in
Table 1 and in Figures 3,4.
Stage 3.Committed progenitors are ~12–15µm diploid, unipotent, immature cells. These
precursors give rise to only one adult cell type. They lose most stem cell gene expression
(e.g. NCAM, Hedgehog proteins), express either hepatocytic or biliary markers, and abound
in fetal and neonatal tissues or chronic liver diseases (viral, alcoholic and non-alcoholic fatty
liver diseases, autoimmune hepatitis, cholangiopathies), unlike normal adult tissues(28).
Committed hepatocytic progenitors, also called intermediate hepatocytes, express albumin,
enzymes associated with glycogen synthesis (e.g. glucose-6-phosphate), and lack biliary
markers (e.g.CK19) and AFP. They are associated with endothelial cell precursors and are
located in vivo in the liver plates between the HBs and the diploid adult hepatocytes.
“Small cholangiocytes” are diploid biliary cells, 6–8µm with cuboidal shape, a high nucleus-
to-cytoplasm ratio, small endoplasmic reticulum(29–30), and are associated with hepatic
stellate cell precursors(13). They co-localize with hHpSCs in the stem cell niche, lining the
canals of Hering, intrahepatic bile ducts and bile ductules with internal diameters below
15µm. Direct links between the canals of Hering and bile ductules, which may traverse the
limiting plate and thus may have an intralobular segment (periportal) in addition to their
intraportal location, support current hypotheses that point to small cholangiocytes as
committed biliary progenitors(31). In human and rodent livers, they express high levels of
the anti-apoptotic proteins annexin V and bcl2 (B-cell lymphoma 2 protein). At a functional
level, they express endothelin receptors type A (EDNRA) and type B (EDNRB),
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endogenous opioid peptides, insulin, histamine (H1), acetylcholine (M3), and α-1-adrenergic
agonists, aquaporin 4; they are negative for the Cl−/HCO3− exchanger and receptors for
secretin or somatostatin. During chronic feeding with bile salts taurocholate and
taurolithocholate, small cholangiocytes express otherwise negative Na+-dependent apical
bile acid transporter (ABAT) de novo, suggesting a role in the cholehepatic recirculation of
bile salts in conditions of overload(32). Finally, cystic fibrosis transmembrane conductance
regulator (CFTR) is present in human, but not rodent, small cholangiocytes(31).
Stages 4–6.Diploid adult cells are the only parenchymal cells with significant proliferative
capacity under all known in vitro or in vivo conditions. Exceptions are in conditions
potentially involving genetic reprogramming through chromatin demethylation, the only
known mechanism for restoring cytokinensis, as occurs in tyrosinemia(33) or with massive
loss of mature parenchymal cells (e.g. >80%) due to a transgene(34). Diploid adult
hepatocytes (“small hepatocytes”), partnered with endothelia, can undergo 6–7 rounds of
division within 3 weeks in culture but have limited subcultivation capacity(19). Large
cholangiocytes, partnered with stellate cells, are columnar shape, display a small nucleus
and conspicuous cytoplasm, an abundant Golgi apparatus between the apical pole and the
nucleus, and rough endoplasmic reticulum more abundant than small cholangiocytes(30,35–
36). Large cholangiocytes line interlobular ducts located in the portal triads. The
connections of hHpSCs in canals of Hering to the septal and segmental bile ducts has not yet
been investigated, and markers in septal ducts, segmental ducts and larger ducts are found
also in cells in peribiliary glands, the stem cell niches of the biliary tree(37). Large
cholangiocytes express CFTR and Cl−/HC03− exchanger, aquaporin 4 and aquaporin 8,
secretin and somatostatin receptors other than receptors for hormones and neuropeptides. In
addition, they express the Na+-dependent bile acid transporter ABAT (apical bile acid
transporter), MDR (multidrug transporter) and MRP (multidrug resistance associated
proteins). When large cholangiocytes are damaged by acute carbon tetrachloride (CCl4) or
GABA administration, small cholangiocytes proliferate, and acquire phenotypical and
functional features of large cholangiocytes(38–39), suggesting that the population of small
cholangiocytes lining the canals of Hering and ductules may represent precursors of large
cholangiocytes lining larger ducts. The integrated differential gene expression between small
and large normal cholangiocytes demonstrate through microarray that the proteins related to
cell proliferation tend to be highly expressed by small cholangiocytes, whereas large
cholangiocytes express functional and differentiated genes(36). This is consistent with
studies showing, either with bile duct injury due to CCl4 and GABA administration or with
bile duct regrowth following partial hepatectomy, that small cholangiocyte proliferation is
activated presumably to repopulate bile ducts. These findings suggest that small
cholangiocytes are less mature, have a high resistance to apoptosis, and have marked
proliferative activities, while large cholangiocytes are more differentiated contributing
mainly to ductal bile secretion and absorption. Therefore, while hepatocytic cell lineages
proceed from periportal areas toward the central vein, cholangiocytes proceed in the
opposite direction from canals of Hering/ductules toward larger ducts. See the online
supplement for further information.
II. Regulation of the Parenchymal Cell Lineages
A. Paracrine Signaling between Epithelial-Mesenchymal Partners
Paracrine signaling is the primary form of regulation between parenchymal cells and
partnering mesenchymal cells and represents classic epithelial-mesenchymal relationships
widely described in developmental biology since the 1930s. A new facet is that coordinate
maturation of these [parenchymal]:[mesenchymal] cell associations, starting with [hHpSCs]:
[angioblasts] and splitting into lineages of [hepatocyte]:[endothelia] and [cholangiocyte]:
[stellate cells], gives rise to lineage-dependent gradients of paracrine signals(13) that govern
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the biological responses of cells at each lineage stage. Defined subsets of these lineage-
dependent paracrine signals, soluble and insoluble matrix ones, can be used to establish cells
at a specific lineage stage in culture (Figure 5).
The intrahepatic stem cell niche contains type III collagen, α6β4 integrin-binding form of
laminin, hyaluronans and a minimally sulfated chondroitin sulfate proteoglycan (CS-PG)
(13). Transition to [hHBs]:[endothelia and stellate cell precursors] results in changes to type
IV collagen, αVβ1 integrin-binding laminin, hyaluronans, more sulfated CS-PGs and forms
of heparan sulfate-PGs (HS-PGs). The [hepatocyte]:[endothelia] lineages are associated with
network collagens (e.g. type IV and VI) and increasingly sulfated forms of HS-PGs ending,
in zone 3, in heparin-PGs (HP-PGs). The [cholangiocyte]:[stellate cell] lineages are
associated with fibrillar collagens (e.g. types I and III) and progression from CS-PGs
towards highly sulfated PGs, including dermatan sulfate-PGs (DS-PGs)(13,17,24). Many
soluble signals bind to and work synergistically with matrix components to regulate cells,
particularly PGs and their glycosaminoglycan chains (GAGs). Matrix-bound soluble signals
are biphasic, yielding mitogenic versus differentiative responses depending on the specific
matrix chemistry with which they are associated.
B. Feedback Loop Signaling
Late lineage stage cells produce positive and negative signaling regulators, including bile
salts, various soluble factors and matrix components(40). Positive regulators include
hepatopoietin, released by dying zone 3 cells that stimulate stem/progenitors expansion (M.
Roach, J. Hambor, unpublished observations). Negative regulators include ecto-
nucleotidases expressed by portal hepatoblasts like NTPDase2, which inhibits purinergic
activation of basolateral P2Y receptors in periportal cholangiocytes under homeostatic
conditions. Conversely, loss of NTPDase2 expression after experimental cholestasis in
portal hepatoblasts allows activation of periportal P2Y receptors and increases
cholangiocyte proliferation(41).
Another facet of regulation is mediated by acetylcholine. It stimulates proliferation of stem/
progenitor cells and cholangiocytes expressing M3 acetylcholine receptors(42). In normal
liver and even after partial hepatectomy, late lineage stage hepatocytes lacking M3 receptors
release acetyl cholinesterase into the bile that delivers it to zone 1 where it destroys
acetylcholine in the stem cell niche, thus blocking proliferation of stem/progenitor cells and
cholangiocytes. In contrast, during conditions of pericentral damage, the acetyl
cholinesterase is not released, resulting secondarily in induction by acetylcholine of stem/
progenitor cell expansion. Denervated transplanted livers lack acetylcholine modulation of
proliferation of cells lining the canals of Hering. Hepatitis-injured transplanted livers also
exhibit lower numbers of progenitor and reactive ductular cells than innervated matched
controls. Experiments in rats with galactosamine-damaged livers confirm that vagotomy
induces impaired regeneration of progenitors and ductal reaction in cholangiocytes(43).
Mechanotransduction mechanisms are another major set affecting lineage biology, most
involving cytoskeletal rearrangements. The cytoskeleton is a ubiquitous cellular component
with characteristics of amplification systems and connections with matrix. Some of these
connections allow cells to sense microenvironment rigidity through non-muscle myosin II,
which directs stiffness-dependent differentiation in mesenchymal stem cells(44). Germ layer
organization and cell sorting depends on cell adhesion forces and cortex tension relying on
actomyosin network activity(45). Integrins connect the cytoskeleton to matrix substrata,
recruit focal adhesions that adapt cells to mechanical stresses, bind ligands and regulate
intracellular signaling(46). Mechanical stretch in liver cells induces activation and synthesis
of morphogens in the TGF-β family of Activin/Nodal signaling(47). SMAD transcription
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factors regulate TGF-β signaling pathways and regulate gene expression through kinesin-
mediated nucleocytoplasmic shuttling along intact microtubules(48–49).
Primary cilia in cells from soft organs also participate in mechanotransduction by probing
and amplifying the effects of intraluminal flow above cell apical surfaces. They mediate
polarized signal transduction pathways that use the cytoskeleton to ensure specific and non-
diffusable signal trafficking to the nucleus(50). PDGRα and Hedgehog signaling take place
in primary cilia(51–52) in livers of all ages(5) through dynein-mediated shuttling of Gli
transcription factors(53). Some chromatin targets of Gli transcription factors include PTCH,
WNT and BMP genes, all involved in embryonic development and differentiation
mechanisms(54–56). Hedgehog expression gradients also demarcate the extension of
endodermal organs during development(52,57). In conjunction, this information suggests
primary cilia are relevant participants in endoderm maturation and differentiation.
Bile secretion is an important mechanism for homeostatic control of tissue mass, operating
as an inductor in mechano-transduction. Bile is a Newtonian fluid in normal physiological
conditions with salt concentration-dependent viscosity(58). Bile tonicity increases while
flowing in the pericentral-to-periportal direction as hepatic parenchyma perform secretory
functions. Abnormal bile tonicity is characteristic of pathological conditions(59). Shear
forces from bile flow, proportional to bile viscosity, can function as long-range mechanical
signals communicating states of hepatic function across the entire liver maturational gradient
to cholangiocytes in the proximal biliary tree through primary cilia bending. This bending
triggers stress-induced Ca2+, cAMP signaling cascades and receptor-mediated PDGRα and
Hedgehog signaling, which makes bile a mechanical probe for liver homeostatic control(42).
Liver Regeneration. Two distinct forms of liver regeneration take place after: a) partial
hepatectomy, and b) selective loss of pericentral cells. After partial hepatectomy, feedback
loop signaling is essentially intact. DNA synthesis occurs in cells across the liver plates but
only a portion of the cells undergo cytokinesis, yielding in increased numbers of polyploid
cells, higher numbers of apoptotic cells, and more rapid turnover of the liver with restoration
of the normal ploidy profiles within weeks(60). Feedback loop signaling is the explanation
for liver cells in culture in which secreted signals from late lineage stage cells inhibit the
growth of any early lineage stage cells(20).
Selective loss of pericentral cells with toxic injury to zone 3 cells (and sometimes also to
zone 2) results in muting of the feedback loop signaling that activates rapid cell division of
early lineage stage cells(12,61). In response, periportal cells undergo rapid hyperplastic
growth (complete cell division) followed by differentiation. These phenomena, the classic
“oval cell response” in rodents and the “ductular reactions” seen in human massive hepatic
necrosis (e.g. acetaminophen toxicity, acute hepatotropic viral infection), have long been
recognized to involve extensive expansion of the stem/progenitor cell populations(12).
Chronic injury to the liver, as occurs with repeated drug exposures, radiation, or certain viral
infections like hepatitis B or C, result in loss of late lineage stage cells, eliciting chronic
regenerative responses.
C. Relevance to Clinical Programs
Hepatic lineage biology and mechanisms of its regulation will have relevance for many
clinical programs. Examples include tissue sourcing for clinical programs, strategies for
liver cell therapies, immunological issues, and most profoundly an understanding of liver
tumors and logical strategies by which to treat liver cancers.
Sourcing of tissue for any clinical therapy is dictated by the proportion of cells at the
different lineage stages in tissue of a given donor age. Fetal and neonatal tissues with
Turner et al. Page 6













lineages skewed towards early stages will be ideal for stem/progenitor cell therapies,
whereas adult livers will be ideal for programs requiring rapid need for late lineage stage
functions.
Liver cell therapies for inborn errors of metabolism will be affected by feedback loop
signaling, since there will be no selection for the transplanted cells over endogenous cells,
necessitating higher numbers of cells to be transplanted. By contrast, patients with liver
failure due to virus, drugs, or radiation (involving a loss of feedback loop signals) can be
transplanted with smaller numbers of cells given the strong selective pressure for
transplanted cells to expand quickly to reconstitute liver mass.
Concerns regarding a need for immunosuppression will be affected by lineage biology. Non-
immunogenic stem/progenitors can acquire immunogenicity with maturation that potentially
can be managed by use of stellate cells, known to produce immunomodulatory signals. Liver
cell therapies should also use grafting methods that optimize liver engraftment and prevent
cell loss to ectopic sites unlike vascular route delivery, especially for stem/progenitors(62).
D. Liver Cancer Stem Cells
The idea that cancers are transformed stem/progenitor cells originated with the pioneering
work of Van Potter in the 1960s, who proposed that hepatomas contain cells undergoing
“blocked ontogeny”(63). This idea was further elucidated for all types of cancers by Barry
Pierce and Stewart Sell(64) who clarified that many functions thought to be related to cancer
(e.g. AFP expression) are normal functions of an expanded stem/progenitor cell population
and that identification of key distinctions must involve comparison of cancer cells to their
normal stem cell(61,65). Indeed, normal stem/progenitor cells are strikingly similar to tumor
cells in morphology, gene expression, and growth properties, and tumors can be identified as
an expanded lineage stage(61,66). The clinical use of stem cells may come with an increased
risk of tumors depending on the donors (e.g. if there are undiagnosed tumor cells among the
endogenous stem cells) and on the patient’s medical condition (e.g. severe
immunosuppression).
Strategies for cancer therapies will be revolutionized if revamped with lineage biology
knowledge. Treatments with drugs or radiation are known to affect later lineage stages
preferentially. If a specific treatment also targets the lineage stage(s) containing malignantly
transformed cells, then the treatment can be curative. If they fail to target that stage, there
will be a lethal rebound effect: the treatment kills cells in later lineage stages, mutes
feedback loop signaling, and secondarily unhinges early lineage stages where malignant
cells reside. Therefore, future cancer therapies should involve strategies identifying the
lineage stage of the tumor and whether the treatment targets that stage or, alternatively, uses
lineage mechanism regulation, such as feedback loop signals, to control the rate of growth of
tumor cells.
III. Conclusions
The intrahepatic maturational lineages begin within the stem cell compartments, located
periportally, and progress through the midacinar region and ending near the central vein.
The parenchymal cells, along with their mesenchymal cell partners, are governed by
gradients of paracrine signals, including sets of soluble factors and insoluble extracellular
matrix components, and by specific mechanical forces. Feedback loop signals regulate the
stem/progenitors, controlling liver mass and tissue regeneration. Understanding stem cell
and lineage biology in the liver and their regulation offers new considerations for basic and
industrial investigations and for more biologically rational clinical program strategies.
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Abbreviations
With respect to specific cellular subpopulations, the species of origin is indicated by a small
letter in front of the abbreviation (r = rat; m=mouse; h= human);
AFP α-fetoprotein
αSMA α- smooth muscle actin
GABA γ-aminobutyric acid
ALB Albumin
ABAT Apical bile acid transporter
bcl2 protein B-cell lymphoma 2 protein
CCl4 Carbon tetracholoride
CS-PG Chondroitin sulfate proteoglycan
CFTR Cystic fibrosis transmembrane conductance regulator
CK Cytokeratin
DS-PG Dermatan sulfate proteoglycan
NTPDase2 Ectonucleotidase
ENDRA and ENDRB Endothelin receptors type A and type B
EpCAM Epithelial cell adhesion molecules
HS-PG Heparan sulfate proteoglycan
HP-PG Heparin proteoglycan
hHBs versus rHBs Hepatoblasts, human versus rat
hHpSTCs versus rHpSTCs Hepatic stellate cells, human versus rat
hHpSCs versus rHpSCs Hepatic stem cells, human versus rat
ICAM Intercellular adhesion molecules
KDR Kinase insert domain receptor
MHC Major histocompatibility complex
MRP Multidrug resistance associated proteins
MDR Multidrug transporter
NCAM Neural cell adhesion molecule
PG Proteoglycan
SHH and IHH proteins Sonic and Indian hedge hog proteins
TGF-β Transforming growth factor beta
VCAM Vascular cell adhesion molecule
VEGFr Vascular endothelial growth factor receptor
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vWF von Willebrand factor
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Schematic image of liver, the biliary tree and panceas and their connections with the
duodenum. The blue stars indicate sites at which there are high numbers of peribiliary
glands, the stem cell niches of the biliary tree.
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Schematic image of intrahepatic maturational lineages.
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Human hepatic stem cell and hepatoblast phenotypes in vivo. a,b) EpCAM expression in
fetal liver: EpCAM expressed in the ductal plate is not only at the cell surface but also in the
cytoplasm. EpCAM expressed in the hepatoblasts is specific to the cell surface. d,e)
EpCAM expression in adult liver: One end of the Canal of Hering connects to the bile duct,
the other end connects to hepatoblasts (arrow), indicating that the hepatoblasts are derived
from primitive hepatic stem cells harbored in Canals of Hering. c) Double staining for
CK-19/AFP and f) Ep-CAM/AFP of human fetal liver in the portal triad area and analyzed
by confocal microscopy. CK-19 (c, green) is expressed not only by remodeling ductal plate
but faintly expressed by some of the hepatoblasst. Ep-CAM (f, green) is detected in all the
parenchymal cells and biliary epithelial cells forming bile duct and ductal plate (DP).
AFP(red) is expressed by hepatoblasts throughout the fetal liver and undetectable in the
ductal plate. (PT: Portal triad; DP: Ductal Plate)
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Human hepatic stem cell and hepatoblast phenotypes in culture. a) Morphology of human
hepatic stem cells and b) human hepatoblasts in culture on plastic. c) Albumin staining of
human hepatic stem cells, transitioning to hepatoblasts. d) hepatic stem cells stained with
NCAM (green) and hepatoblasts stained with ICAM (red).
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Schematic image indicating the Coordinate Maturation of the Epithelia (Parenchymal cells)
and their Mesenchymal Partners and some of the identified extracellular matrix components
found at the particular lineage stages. Not shown in the figure are the soluble signals that
also are lineage dependent. Some of those identified and that are lineage dependent are:
hepatic stem cells are LIF, IL-6, IL-11, and acetylcholine; hepatoblasts are HGF, EGF,
bFGF, IL-6, IL-11, and acetylcholine; hepatocytes are HGF, EGF, bFGF, T3, glucagon, and
hydrocortisone; cholangiocytes are VEGF, HGF, bFGF. and acetylcholine.
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Table 1
Phenotypic Profiles of Multipotent Cell Populations in Human Livers




Average diameter (measured by forward scatter
in flow cytometric analyses of isolated cells)
7–9 µm 10–12 µm
Nucleus to cytoplasmic ratio Highest observed of all parenchymal
progenitor subpopulations evaluated
Intermediate between that in hHpSCs and
mature parenchymal cells
Percentage of parenchymal cells(7) 0.5–1.5 % in livers of all donor ages and
with minimal ischemia; percentages higher
in ischemic livers
>80% (fetal livers)
~50% (neonatal livers) [percentages
change rapidly day by day postnatally]
<0.01% (adult livers)
Survival after cardiac arrest (tolerance for
ischemia)(7)
Viable cells for several days after cardiac
arrest
Viable for more than a day, but not as
long as hHpSCs
Morphology of colonies in vitro (7) Uniform; densely packed; look similar to ES
cell colonies
Cord-like colonies interspersed with clear
channels that are presumptive canaliculi
Evidence for Self-renewal(17) Clonogenic expansion with stability of
phenotype; doubling times of ~36 hours on
plastic; can be passaged repeatedly; fastest
doubling times (~20–24 hours) for hHpSCs
on substrata of type III collagen
Significant expansion potential but not
yet evidence for self-replication (under
the conditions tested to date). Probable
transit amplifying cells
Pluripotency(7) Multipotent Bipotent
Anaerobic metabolism (metabolomic studies)
(21)
+++ +++
Conditions for clonogenic expansion(19) Kubota’s Medium plus feeders of
angioblasts replaceable with type III
collagen (monolayers) or hyaluronans into
which is mixed type III collagen (3-D)
Kubota’s Medium plus feeders of hepatic
stellate cells replaceable with type IV
collagen/laminin (monolayers) or
hyaluronans into which is mixed type IV
collagen/laminin (3-D)
CD44 (hyaluronan receptor)(24) High concentrations High concentrations
Claudin 3(16) +++ Negative
Indian Hedgehog(5) +++ Highest level in cells in the center of
the colonies
++ Lower levels, but pattern of
distribution is the same
Sonic Hedgehog(5) ++ Located at edge of cells; concentrated in
cells at edge of colonies at sites of high
concentration of angioblasts
+ Lower levels, but pattern of distribution
is the same
Patched (Hedgehog receptor)(5) +++ Found in all cells and in colonies
throughout the colony
++ Levels lower, but still evident
Telomerase(27) + mRNA encoding telomerase and the
protein found in nucleus. No telomerase
protein in the cytoplasm
+++ mRNA encoding telomerase and the
protein found in nucleus; with
differentiation, increasing numbers of the
cells have it in the cytoplasm; 5X higher
activity than in hHpSCs
P450s(16) Negative for all assayed P450 A7 but not late forms of P450s
CK 8 and 18(16) ++ ++
CK 19 (7,16) ++ (not in filament form) ++ (filaments evident)
E-cadherin(7) ++ ++
EpCAM(7–8) +++ (throughout the cells) ++ (plasma membrane)
NCAM /ICAM-1(7–8) ++ /− −/++
Albumin(7) ± ++
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*Mesenchymal Markers Negative Negative
**Angioblasts/Endothelial cell Markers Negative Negative
***Hemopoietic markers Negative Negative
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